{"id":"https://openalex.org/W4402807249","doi":"https://doi.org/10.1158/0008-5472.27028516.v1","title":"Supplementary Table 1 from Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers","display_name":"Supplementary Table 1 from Abemaciclib is effective in palbociclib-resistant hormone receptor-positive metastatic breast cancers","publication_year":2024,"publication_date":"2024-09-16","ids":{"openalex":"https://openalex.org/W4402807249","doi":"https://doi.org/10.1158/0008-5472.27028516.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.27028516.v1","doi":"https://doi.org/10.1158/0008-5472.27028516.v1","is_oa":true,"landing_page_url":"http://doi.org/10.1158/0008-5472.27028516.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://doi.org/10.1158/0008-5472.27028516.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017644527","display_name":"Juliana Navarro-Yepes","orcid":"https://orcid.org/0000-0003-0393-3773","observed_orcids":["https://orcid.org/0000-0003-0393-3773"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliana Navarro-Yepes","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0393-3773","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026936750","display_name":"Nicole M. Kettner","orcid":"https://orcid.org/0000-0003-2043-4407","observed_orcids":["https://orcid.org/0000-0003-2043-4407"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicole M. Kettner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2043-4407","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077700916","display_name":"Xiayu Rao","orcid":"https://orcid.org/0000-0001-5245-7449","observed_orcids":["https://orcid.org/0000-0001-5245-7449"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiayu Rao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5245-7449","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107385205","display_name":"Cassandra Santaella Bishop","orcid":"https://orcid.org/0000-0001-9153-9615","observed_orcids":["https://orcid.org/0000-0001-9153-9615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cassandra Santaella. Bishop","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9153-9615","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000113218","display_name":"Tuyen N. Bui","orcid":"https://orcid.org/0000-0001-8509-3653","observed_orcids":["https://orcid.org/0000-0001-8509-3653"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tuyen N. Bui","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8509-3653","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052218127","display_name":"Hannah F. Wingate","orcid":"https://orcid.org/0000-0002-1055-8935","observed_orcids":["https://orcid.org/0000-0002-1055-8935"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hannah F. Wingate","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1055-8935","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016698215","display_name":"Akshara Singareeka Raghavendra","orcid":"https://orcid.org/0000-0002-6425-4400","observed_orcids":["https://orcid.org/0000-0002-6425-4400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akshara Singareeka Raghavendra","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6425-4400","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057311999","display_name":"Yan Wang","orcid":"https://orcid.org/0000-0001-9566-8975","observed_orcids":["https://orcid.org/0000-0001-9566-8975"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yan Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9566-8975","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5398-0802","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041098535","display_name":"Ay\u015feg\u00fcl A. \u015eahin","orcid":"https://orcid.org/0000-0001-8259-9624","observed_orcids":["https://orcid.org/0000-0001-8259-9624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aysegul A. Sahin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8259-9624","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076426660","display_name":"Funda Meric\u2010Bernstam","orcid":"https://orcid.org/0000-0001-6816-6072","observed_orcids":["https://orcid.org/0000-0001-6816-6072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Funda Meric-Bernstam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6816-6072","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017411324","display_name":"Kelly K. Hunt","orcid":"https://orcid.org/0000-0001-9156-8723","observed_orcids":["https://orcid.org/0000-0001-9156-8723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly K. Hunt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9156-8723","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009582590","display_name":"Senthil Damodaran","orcid":"https://orcid.org/0000-0002-2470-0891","observed_orcids":["https://orcid.org/0000-0002-2470-0891"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Senthil Damodaran","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2470-0891","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debu Tripathy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5711-2404","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5440-0849","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/palbociclib-resistance","display_name":"palbociclib resistance","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.970893383026123},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6472777724266052},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6452521681785583},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5765836238861084},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.5535755157470703},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5411031246185303},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4496850371360779},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43535757064819336},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27606475353240967}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.27028516.v1","doi":"https://doi.org/10.1158/0008-5472.27028516.v1","is_oa":true,"landing_page_url":"http://doi.org/10.1158/0008-5472.27028516.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/27028516","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Supplementary_Table_1_from_Abemaciclib_is_effective_in_palbociclib-resistant_hormone_receptor-positive_metastatic_breast_cancers/27028516","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.27028516.v1","doi":"https://doi.org/10.1158/0008-5472.27028516.v1","is_oa":true,"landing_page_url":"http://doi.org/10.1158/0008-5472.27028516.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402803460","https://openalex.org/W4382541721","https://openalex.org/W3081157094","https://openalex.org/W3161515104","https://openalex.org/W4396587858","https://openalex.org/W6976728261","https://openalex.org/W4315490807","https://openalex.org/W7162568203","https://openalex.org/W4229063635","https://openalex.org/W4399238136"],"abstract_inverted_index":{"This":[0],"file":[1],"contains":[2],"Supplementary":[3],"Table":[4],"1,":[5],"pertaining":[6],"to":[7],"the":[8],"proteomic":[9],"classification":[10],"of":[11],"RPPA":[12],"antibodies":[13]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-09-25T00:00:00"}